Gastritis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

 

Gastritis refers to inflammation of the stomach lining, a medical condition that can be categorized based on its duration (acute or chronic), histological features, or underlying causes. Acute gastritis is a transient inflammation resulting from stress on the gastric mucosa, presenting with either hemorrhagic or non-hemorrhagic symptoms. Chronic gastritis, on the other hand, presents as either atrophic or non-atrophic forms. The primary culprit behind chronic gastritis is often Helicobacter pylori infection, typically beginning with a non-atrophic presentation. The pathophysiology of H. pylori-induced gastritis involves intricate interactions between bacterial virulence factors and the host's immune responses. Diagnosis primarily relies on histopathological examination of gastric biopsies. Initial treatment for patients with dyspepsia and documented H. pylori infection typically involves eradication therapy. This approach is also indicated in cases of peptic ulcer disease, functional dyspepsia, idiopathic thrombocytopenic purpura (ITP), unexplained iron-deficiency anemia, and in individuals anticipating long-term nonsteroidal anti-inflammatory drug (NSAID) therapy, especially those with a history of peptic ulcer disease.

• The prevalence of moderate-to-severe antral gastritis in the United States was 75.0% in erosive esophagitis, 27.8% in non-ulcer dyspepsia, and 29.5% in non-erosive reflux disease H pylori - patients.

Thelansis’s “Gastritis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Gastritis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Gastritis across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Gastritis Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Gastritis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033